EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Levothyroxine: Conventional and Novel Drug Delivery Formulations

Hanqing Liu iD, Wei Li iD, Wen Zhang iD, Shengrong Sun iD, Chuang Chen iD

Endocrine Reviews · 08.05.2023 · 44 (3) · 393-416

DOI: 10.1210/endrev/bnac030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 22.11.2022. Verfasst von Hanqing Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: Thyroxine, Hypothyroidism. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 279 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Xisike Clinical Oncology Research Foundation, Fundamental Research Funds, Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although levothyroxine is one of the most prescribed medications in the world, its bioavailability has been reported to be impaired by many factors, including interfering drugs or foods and concomitant diseases, and persistent hypothyroidism with a high dose of levothyroxine is thus elicited. Persistent hypothyroidism can also be induced by noninterchangeability between formulations and poor compliance. To address these issues some strategies have been developed. Novel formulations (liquid solutions and soft gel capsules) have been designed to eliminate malabsorption. Some other delivery routes (injections, suppositories, sprays, and sublingual and transdermal administrations) are aimed at circumventing different difficulties in dosing, such as thyroid emergencies and dysphagia. Moreover, nanomaterials have been used to develop delivery systems for the sustained release of levothyroxine to improve patient compliance and reduce costs. Some delivery systems encapsulating nanoparticles show promising release profiles. In this review, we first summarize the medical conditions that interfere with the bioavailability of oral levothyroxine and discuss the underlying mechanisms and treatments. The efficacy of liquid solutions and soft gel capsules are systematically evaluated. We further summarize the novel delivery routes for levothyroxine and their possible applications. Nanomaterials in the levothyroxine field are then discussed and compared based on their load and release profile. We hope the article provides novel insights into the drug delivery of levothyroxine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroxineHypothyroidismHumansCapsules

Stichwörter der Autor:innen

LT4injectionliquid solutionmalabsorptionnanoparticlesoft gel capsule

Substanzen

ThyroxineCapsules

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, People's Republic of China.
  • Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Ministry of Education), School of Pharmaceutical Sciences, Wuhan University, Wuhan 430060, Hubei, People's Republic of China.

ORCID-Profile: Hanqing Liu, Wei Li, Wen Zhang, Shengrong Sun, Chuang Chen

Förderung

  • Beijing Xisike Clinical Oncology Research Foundation
  • Fundamental Research Funds
  • Central Universities
  • Science and Technology Major Project of Hubei Province
  • Next-Generation AI Technologies

Zitieren

APA

Liu, H., Li, W., Zhang, W., Sun, S., & Chen, C. (2023). Levothyroxine: Conventional and Novel Drug Delivery Formulations. Endocrine Reviews, 44(3), 393-416. https://doi.org/10.1210/endrev/bnac030

Vancouver

Liu H, Li W, Zhang W, Sun S, Chen C. Levothyroxine: Conventional and Novel Drug Delivery Formulations. Endocrine Reviews. 2023;44(3):393-416. doi:10.1210/endrev/bnac030

BibTeX
@article{Liu2023,
  author = {Liu, Hanqing and Li, Wei and Zhang, Wen and Sun, Shengrong and Chen, Chuang},
  title = {Levothyroxine: Conventional and Novel Drug Delivery Formulations},
  journal = {Endocrine Reviews},
  year = {2023},
  volume = {44},
  number = {3},
  pages = {393--416},
  doi = {10.1210/endrev/bnac030}
}
Kostenlos starten →